Navigating the Fight: Understanding Immunotherapy for Skin Cancer

March 4, 2024

Featured image for “Navigating the Fight: Understanding Immunotherapy for Skin Cancer”

Skin cancer is one of the most prevalent cancers worldwide, with over 5 million cases diagnosed annually. The three main types of skin cancer are melanoma, basal cell carcinoma, and squamous cell carcinoma. Of these, melanoma is the deadliest form and accounts for most skin cancer deaths. However, new treatment approaches like immunotherapy offer promising options for managing various skin cancers. This article provides an overview of how immunotherapy works and its effectiveness for different types of skin cancer.

Demystifying Immunotherapy

What is Immunotherapy?

“Immunotherapy empowers the body’s natural defenses to recognize and attack cancer cells, offering a distinct approach to cancer treatment.”

At its core, immunotherapy utilizes the body’s immune system to fight cancer. It works by enhancing, directing, or restoring the immune system’s ability to eliminate cancer cells. This unique mechanism sets it apart from conventional treatment modalities like chemotherapy and radiation.

There are several approaches to immunotherapy:

  • Checkpoint inhibitors: These drugs block proteins that act as “brakes” on immune responses, allowing immune cells to better recognize and destroy cancer cells. Examples include pembrolizumab, nivolumab, and cemiplimab.
  • Tumor-infiltrating lymphocyte (TIL) therapy: This involves isolating TILs from tumor tissue and growing large numbers of them in the lab. These enhanced TILs are then infused back into the patient to drive an immune attack against cancer cells.
  • Bacille Calmette-Guerin (BCG) vaccine: BCG stimulates the immune system and may boost the immune response against cancer cells. It is sometimes used to treat early-stage skin cancers.

Different Forms of Immunotherapy for Skin Cancer

While other forms exist, checkpoint inhibitors and TIL therapy are the most widely used immunotherapeutic approaches for skin cancer. The choice depends on cancer type, stage, patient health profile, and more.

Effectiveness of Immunotherapy for Different Skin Cancers


Immunotherapy has transformed advanced melanoma treatment, significantly improving survival rates and the potential for long-term remission. Key immunotherapy drugs used for melanoma include:

  • Pembrolizumab
  • Nivolumab
  • Ipilimumab

One analysis showed a 63% 5-year survival rate for advanced melanoma patients treated with a combination of nivolumab and ipilimumab immunotherapy drugs.

Other Skin Cancers

While most skin cancer research focuses on melanoma, some studies indicate potential for using immunotherapy to treat basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). However, more evidence is required to confirm effectiveness against non-melanoma skin cancers.

Due to variability in responses, it’s vital to consult a healthcare professional regarding treatment options tailored to your unique diagnosis and medical profile.

Important Considerations

Not a Cure for All

Despite remarkable advancement, immunotherapy does not represent an outright cure for all skin cancer cases. Individual patient factors like genetics, lifestyle, and cancer stage influence whether immunotherapy achieves full remission or if integrating it with other therapies is more prudent.

Potential Side Effects

As with other cancer treatments, immunotherapy may cause immune-related side effects based on the specific drug used. These could include fatigue, skin reactions, hormone gland inflammation, diarrhea, and more. Proactively communicating with your care team helps manage potential side effects.

Importance of Individualized Treatment Plans

There is no universally applicable skin cancer treatment pathway. Creating a personalized immunotherapy regimen requires assessing the tumor molecular profile, immune function baselines, treatment history, and other critical health parameters. Partnering with an experienced oncologist can help map out an integrated treatment plan aligned to your unique needs.

Frequently Asked Questions

Is immunotherapy suitable for all stages of skin cancer?

Immunotherapy efficacy varies by cancer type and stage. While often used for advanced skin cancers, its suitability depends on individual factors. Consult an oncologist for guidance.

What are the success rates of immunotherapy for skin cancer?

Outcomes differ based on cancer type, stage, immunotherapy drugs used, and more. But milestone studies report significant survival benefits, especially for advanced melanoma.

What are the potential side effects of immunotherapy for skin cancer?

Common side effects include fatigue, skin reactions, hormone inflammation, diarrhea, and more. Proactively monitoring side effects with your care team enables timely management.

Can immunotherapy be combined with other treatments for skin cancer?

Yes, immunotherapy is often combined with surgery, radiation, targeted therapy, or chemotherapy as part of a comprehensive treatment plan.

How do I know if immunotherapy is right for me?

Have an open discussion with your oncologist regarding your diagnosis, treatment goals, medical history, genetics, lifestyle, and more to determine if immunotherapy is suitable.

Key Takeaways

  • Immunotherapy helps treat skin cancers by directing the body’s immune defenses against cancer cells.
  • It has shown tremendous promise for advanced and metastatic melanoma.
  • Effectiveness for non-melanoma skin cancers requires more research.
  • It represents one component of rapidly evolving skin cancer treatment options.
  • Creating a personalized immunotherapy treatment regimen is crucial for optimal outcomes.
5/5 - (1 vote)

Related articles


Cold Plasma System

The world's first handheld cold plasma device

Learn More

Made in USA